The Evaluation of Plasma and Leukocytic IL-37 Expression in Early Inflammation in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI

Objective. Acute ST-segment elevation myocardial infarction (ASTEMI) is accompanied by increased expression of inflammation and decreased expression of anti-inflammation. IL-37 was found to be involved in the atherosclerosis-related diseases and increased in acute coronary syndrome. However, the lev...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin Wang, Xiangna Cai, Lan Chen, Duanmin Xu, Jilin Li
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2015/626934
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561730310373376
author Xin Wang
Xiangna Cai
Lan Chen
Duanmin Xu
Jilin Li
author_facet Xin Wang
Xiangna Cai
Lan Chen
Duanmin Xu
Jilin Li
author_sort Xin Wang
collection DOAJ
description Objective. Acute ST-segment elevation myocardial infarction (ASTEMI) is accompanied by increased expression of inflammation and decreased expression of anti-inflammation. IL-37 was found to be involved in the atherosclerosis-related diseases and increased in acute coronary syndrome. However, the level of IL-37 in blood plasma and leukocytes from patients with ASTEMI after percutaneous coronary intervention (PCI) has not been explored. Methods. We collected peripheral venous blood from consented patients at 12 h, 24 h, and 48 h after PCI and healthy volunteers. Plasma IL-37, IL-18, IL-18-binding protein (BP), and high sensitive C reaction protein (hs-CRP) were quantified by ELISA and leukocytic IL-37 and ICAM-1 by immunoblotting. Results. Plasma IL-37, IL-18, and IL-18 BP expression decreased compared to those in healthy volunteers while hs-CRP level was high. Both leukocytic IL-37 and ICAM-1 were highest expressed at 12 h point but significantly decreased at 48 h point. Conclusion. These findings suggest L-37 does not play an important role in the systematic inflammatory response but may be involved in leukocytic inflammation in ASTEMI after PCI.
format Article
id doaj-art-b802c154f1844927bb3dd91743917c61
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-b802c154f1844927bb3dd91743917c612025-02-03T01:24:24ZengWileyMediators of Inflammation0962-93511466-18612015-01-01201510.1155/2015/626934626934The Evaluation of Plasma and Leukocytic IL-37 Expression in Early Inflammation in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCIXin Wang0Xiangna Cai1Lan Chen2Duanmin Xu3Jilin Li4Department of Cardiology, First Affiliated Hospital of Shantou University Medical College, No. 57, Changping Road, Shantou, Guangdong 515041, ChinaDepartment of Plastic Surgery, First Affiliated Hospital of Shantou University Medical College, No. 57, Changping Road, Shantou, Guangdong 515041, ChinaDepartment of Cardiology, First Affiliated Hospital of Shantou University Medical College, No. 57, Changping Road, Shantou, Guangdong 515041, ChinaDepartment of Cardiology, First Affiliated Hospital of Shantou University Medical College, No. 57, Changping Road, Shantou, Guangdong 515041, ChinaDepartment of Cardiology, First Affiliated Hospital of Shantou University Medical College, No. 57, Changping Road, Shantou, Guangdong 515041, ChinaObjective. Acute ST-segment elevation myocardial infarction (ASTEMI) is accompanied by increased expression of inflammation and decreased expression of anti-inflammation. IL-37 was found to be involved in the atherosclerosis-related diseases and increased in acute coronary syndrome. However, the level of IL-37 in blood plasma and leukocytes from patients with ASTEMI after percutaneous coronary intervention (PCI) has not been explored. Methods. We collected peripheral venous blood from consented patients at 12 h, 24 h, and 48 h after PCI and healthy volunteers. Plasma IL-37, IL-18, IL-18-binding protein (BP), and high sensitive C reaction protein (hs-CRP) were quantified by ELISA and leukocytic IL-37 and ICAM-1 by immunoblotting. Results. Plasma IL-37, IL-18, and IL-18 BP expression decreased compared to those in healthy volunteers while hs-CRP level was high. Both leukocytic IL-37 and ICAM-1 were highest expressed at 12 h point but significantly decreased at 48 h point. Conclusion. These findings suggest L-37 does not play an important role in the systematic inflammatory response but may be involved in leukocytic inflammation in ASTEMI after PCI.http://dx.doi.org/10.1155/2015/626934
spellingShingle Xin Wang
Xiangna Cai
Lan Chen
Duanmin Xu
Jilin Li
The Evaluation of Plasma and Leukocytic IL-37 Expression in Early Inflammation in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI
Mediators of Inflammation
title The Evaluation of Plasma and Leukocytic IL-37 Expression in Early Inflammation in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI
title_full The Evaluation of Plasma and Leukocytic IL-37 Expression in Early Inflammation in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI
title_fullStr The Evaluation of Plasma and Leukocytic IL-37 Expression in Early Inflammation in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI
title_full_unstemmed The Evaluation of Plasma and Leukocytic IL-37 Expression in Early Inflammation in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI
title_short The Evaluation of Plasma and Leukocytic IL-37 Expression in Early Inflammation in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI
title_sort evaluation of plasma and leukocytic il 37 expression in early inflammation in patients with acute st segment elevation myocardial infarction after pci
url http://dx.doi.org/10.1155/2015/626934
work_keys_str_mv AT xinwang theevaluationofplasmaandleukocyticil37expressioninearlyinflammationinpatientswithacutestsegmentelevationmyocardialinfarctionafterpci
AT xiangnacai theevaluationofplasmaandleukocyticil37expressioninearlyinflammationinpatientswithacutestsegmentelevationmyocardialinfarctionafterpci
AT lanchen theevaluationofplasmaandleukocyticil37expressioninearlyinflammationinpatientswithacutestsegmentelevationmyocardialinfarctionafterpci
AT duanminxu theevaluationofplasmaandleukocyticil37expressioninearlyinflammationinpatientswithacutestsegmentelevationmyocardialinfarctionafterpci
AT jilinli theevaluationofplasmaandleukocyticil37expressioninearlyinflammationinpatientswithacutestsegmentelevationmyocardialinfarctionafterpci
AT xinwang evaluationofplasmaandleukocyticil37expressioninearlyinflammationinpatientswithacutestsegmentelevationmyocardialinfarctionafterpci
AT xiangnacai evaluationofplasmaandleukocyticil37expressioninearlyinflammationinpatientswithacutestsegmentelevationmyocardialinfarctionafterpci
AT lanchen evaluationofplasmaandleukocyticil37expressioninearlyinflammationinpatientswithacutestsegmentelevationmyocardialinfarctionafterpci
AT duanminxu evaluationofplasmaandleukocyticil37expressioninearlyinflammationinpatientswithacutestsegmentelevationmyocardialinfarctionafterpci
AT jilinli evaluationofplasmaandleukocyticil37expressioninearlyinflammationinpatientswithacutestsegmentelevationmyocardialinfarctionafterpci